These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8286827)

  • 21. Comparison of quantitative cDNA-PCR with the branched DNA hybridization assay for monitoring plasma hepatitis C virus RNA levels in haemophilia patients participating in a controlled interferon trial.
    Bresters D; Cuypers HT; Reesink HW; Mauser-Bunschoten EP; van den Berg HM; Schaasberg WP; Wilber JC; Urdea MS; Neuwald P; Lelie PN
    J Med Virol; 1994 Jul; 43(3):262-8. PubMed ID: 7931188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A long-term follow-up study of interferon treatment for chronic hepatitis C in Japanese patients with congenital bleeding disorders.
    Yamada M; Fukuda Y; Koyama Y; Nakano I; Urano F; Isobe K; Takamatsu J; Imoto M; Hayakawa T
    Eur J Haematol; 1996 Aug; 57(2):165-70. PubMed ID: 8856094
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genotypes and titers of hepatitis C virus for predicting response to interferon in patients with chronic hepatitis C.
    Hino K; Sainokami S; Shimoda K; Iino S; Wang Y; Okamoto H; Miyakawa Y; Mayumi M
    J Med Virol; 1994 Mar; 42(3):299-305. PubMed ID: 7516422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infection.
    Weiland O; Chen M; Lindh G; Mattsson L; Schvarcz R; Sönnerborg A; Wahl M; Wejstål R; Widell A; Norkrans G
    Scand J Infect Dis; 1995; 27(5):319-24. PubMed ID: 8588128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes in antibody titers to hepatitis C virus following interferon therapy for chronic infection.
    Urushihara A; Sodeyama T; Matsumoto A; Tanaka E
    J Med Virol; 1994 Apr; 42(4):348-56. PubMed ID: 7519250
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum levels of soluble interleukin-2 receptor in chronic hepatitis C treated with interferon-alpha.
    Morishima I; Kumada T; Nakano S; Takeda I; Sugiyama K; Osada T; Kiriyama S; Ohki H; Suga T; Ito O
    Scand J Gastroenterol; 1995 Aug; 30(8):807-11. PubMed ID: 7481551
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Testing for hepatitis C virus sequences in peripheral blood mononuclear cells of patients with chronic hepatitis C in the absence of serum hepatitis C virus RNA.
    Muratori L; Giostra F; Cataleta M; Francesconi R; Ballardini G; Cassani F; Lenzi M; Bianchi FB
    Liver; 1994 Jun; 14(3):124-8. PubMed ID: 8078391
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Discordance between serum alanine aminotransferase (ALT) and virologic response to IFN-alpha2b in chronic hepatitis C patients with high and low pretreatment serum hepatitis C virus RNA titers.
    Blatt LM; Tong MJ; McHutchison JG; Russell J; Schmid P; Conrad A
    J Interferon Cytokine Res; 1998 Feb; 18(2):75-80. PubMed ID: 9506457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HCV-RNA assay in peripheral blood mononuclear cells in relation to IFN therapy.
    Okuda M
    Gastroenterol Jpn; 1993 Aug; 28(4):535-40. PubMed ID: 8397131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interferon and ursodeoxycholic acid combined therapy in the treatment of chronic viral C hepatitis: results from a controlled randomized trial in 80 patients.
    Boucher E; Jouanolle H; Andre P; Ruffault A; Guyader D; Moirand R; Turlin B; Jacquelinet C; Brissot P; Deugnier Y
    Hepatology; 1995 Feb; 21(2):322-7. PubMed ID: 7843700
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum levels of hepatitis C virus core protein in patients with chronic hepatitis C treated with interferon alfa.
    Tanaka E; Kiyosawa K; Matsumoto A; Kashiwakuma T; Hasegawa A; Mori H; Yanagihara O; Ohta Y
    Hepatology; 1996 Jun; 23(6):1330-3. PubMed ID: 8675147
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HCV viraemia is more important than genotype as a predictor of response to interferon in Sicily (southern Italy).
    Magrin S; Craxi A; Fabiano C; Marino L; Fiorentino G; Lo Iacono O; Volpes R; Di Marco V; Almasio P; Vaccaro A; Urdea MS; Wilber JC; Bonura C; Gianguzza F; Capursi V; Filiberti S; Stuyver L; Pagliaro L
    J Hepatol; 1996 Nov; 25(5):583-90. PubMed ID: 8938531
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Patterns of hepatitis C viremia in patients receiving hemodialysis.
    Umlauft F; Gruenewald K; Weiss G; Kessler H; Urbanek M; Haun M; Santner B; Koenig P; Keeffe EB
    Am J Gastroenterol; 1997 Jan; 92(1):73-8. PubMed ID: 8995941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Virological and biochemical long-term follow-up of patients with chronic hepatitis C treated with interferon.
    Castillo I; Bartolomé J; Navas S; Gonzalez S; Herrero M; Carreño V
    Hepatology; 1994 Jun; 19(6):1342-6. PubMed ID: 8188165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Virological response to interferon treatment in hepatitis C virus carriers with normal aminotransferase levels and chronic hepatitis.
    Rossini A; Ravaggi A; Biasi L; Agostinelli E; Bercich L; Gazzola GB; Callea F; Radaeli E; Cariani E
    Hepatology; 1997 Oct; 26(4):1012-7. PubMed ID: 9328328
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantification of the initial decline of serum hepatitis C virus RNA and response to interferon alfa.
    Zeuzem S; Lee JH; Franke A; Rüster B; Prümmer O; Herrmann G; Roth WK
    Hepatology; 1998 Apr; 27(4):1149-56. PubMed ID: 9537457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interferon-alpha therapy for hepatitis C virus infection after liver transplantation.
    Wright TL; Combs C; Kim M; Ferrell L; Bacchetti P; Ascher N; Roberts J; Wilber J; Sheridan P; Urdea M
    Hepatology; 1994 Oct; 20(4 Pt 1):773-9. PubMed ID: 7927216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunoregulatory cytokines in chronic hepatitis C virus infection: pre- and posttreatment with interferon alfa.
    Cacciarelli TV; Martinez OM; Gish RG; Villanueva JC; Krams SM
    Hepatology; 1996 Jul; 24(1):6-9. PubMed ID: 8707283
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The fluctuations of hepatitis C virus RNA and IgM anti-HCV (core) serum levels correlate with those of alanine aminotransferases during the hepatitis relapses of patients treated with interferon.
    Negro F; Abate ML; Mondardini A; Baldi M; Leandro G; Lombardi S; Wolfe L; Ryff JC; Verme G; Brunetto MR
    J Viral Hepat; 1995; 2(4):171-4. PubMed ID: 7489343
    [TBL] [Abstract][Full Text] [Related]  

  • 40. alpha-Interferon treatment of chronic hepatitis C in young patients with homozygous beta-thalassemia.
    Di Marco V; Lo Iacono O; Capra M; Grutta S; Ciaccio C; Gerardi C; Maggio A; Renda D; Almasio P; Pisa R
    Haematologica; 1992; 77(6):502-6. PubMed ID: 1289187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.